Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1073

1.

Two year efficacy and safety of small versus large ABSORB bioresorbable vascular scaffolds of ≤18 mm device length: A subgroup analysis of the German-Austrian ABSORB RegIstRy (GABI-R).

Zaczkiewicz M, Wein B, Graf M, Zimmermann O, Kastner J, Wöhrle J, Thomas R, Hamm C, Torzewski J; GABI-R Study Group.

Int J Cardiol Heart Vasc. 2020 Mar 20;27:100501. doi: 10.1016/j.ijcha.2020.100501. eCollection 2020 Apr.

2.

SPARCL1 as a biomarker of maladaptive right ventricular remodelling in pulmonary hypertension.

Keranov S, Dörr O, Jafari L, Liebetrau C, Keller T, Troidl C, Kriechbaum S, Voss S, Richter M, Tello K, Gall H, Ghofrani HA, Mayer E, Seeger W, Hamm CW, Nef H.

Biomarkers. 2020 Apr 5:1-6. doi: 10.1080/1354750X.2020.1745889. [Epub ahead of print]

PMID:
32248722
3.

Five-year follow-up of patients who underwent everolimus-eluting bioresorbable scaffold implantation.

Wiebe J, Hofmann FJ, Dörr O, Bauer T, Boeder N, Liebetrau C, Blachutzik F, Möllmann H, Elsässer A, Achenbach S, Hamm CW, Nef HM.

Catheter Cardiovasc Interv. 2020 Mar 18. doi: 10.1002/ccd.28843. [Epub ahead of print]

PMID:
32187817
4.

Long-term follow-up and predictors of target lesion failure after implantation of everolimus-eluting bioresorbable scaffolds in real-world practice.

Wiebe J, Baquet M, Dörr O, Hoppmann P, Jochheim D, Rheude T, Boeder N, Grundman D, Blachutzik F, Theiss H, Cassese S, Hofmann FJ, Gschwendtner S, Elsässer A, Massberg S, Hamm C, Laugwitz KL, Byrne RA, Mehilli J, Kastrati A, Nef H.

Int J Cardiol. 2020 Feb 27. pii: S0167-5273(19)35753-5. doi: 10.1016/j.ijcard.2020.02.062. [Epub ahead of print]

PMID:
32151443
5.

Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERS.

de Faria AP, Modolo R, Chichareon P, Chang CC, Kogame N, Tomaniak M, Takahashi K, Rademaker-Havinga T, Wykrzykowska J, de Winter RJ, Ferreira RC, Sousa A, Lemos PA, Garg S, Hamm C, Juni P, Vranckx P, Valgimigli M, Windecker S, Onuma Y, Steg PG, Serruys PW.

Can J Cardiol. 2019 Oct 19. pii: S0828-282X(19)31350-9. doi: 10.1016/j.cjca.2019.10.015. [Epub ahead of print]

PMID:
32139280
6.

DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCI.

Chichareon P, Modolo R, Kawashima H, Takahashi K, Kogame N, Chang CC, Tomaniak M, Ono M, Walsh S, Suryapranata H, Cotton J, Koning R, Akin I, Kukreja N, Wykrzykowska J, Piek JJ, Garg S, Hamm C, Steg PG, Jüni P, Vranckx P, Valgimigli M, Windecker S, Onuma Y, Serruys PW.

JACC Cardiovasc Interv. 2020 Mar 9;13(5):634-646. doi: 10.1016/j.jcin.2019.12.018.

PMID:
32139222
7.

Patterns of Ruxolitinib Therapy Failure and Its Management in Myelofibrosis: Perspectives of the Canadian Myeloproliferative Neoplasm Group.

Gupta V, Cerquozzi S, Foltz L, Hillis C, Devlin R, Elsawy M, Grewal K, Hamm C, McNamara C, Sirhan S, Leber B.

JCO Oncol Pract. 2020 Mar 5:JOP1900506. doi: 10.1200/JOP.19.00506. [Epub ahead of print]

PMID:
32134707
8.

Impact of Predilatation Prior to Transcatheter Aortic Valve Implantation With the Self-Expanding Acurate neo Device (from the Multicenter NEOPRO Registry).

Pagnesi M, Kim WK, Conradi L, Barbanti M, Stefanini GG, Schofer J, Hildick-Smith D, Pilgrim T, Abizaid A, Zweiker D, Testa L, Taramasso M, Wolf A, Webb JG, Sedaghat A, Van der Heyden JAS, Ziviello F, MacCarthy P, Hamm CW, Bhadra OD, Schäfer U, Costa G, Tamburino C, Cannata F, Reimers B, Eitan A, Alsanjari O, Asami M, Windecker S, Siqueira D, Schmidt A, Bianchi G, Bedogni F, Saccocci M, Maisano F, Jensen CJ, Naber CK, Alenezi A, Wood DA, Sinning JM, Brouwer J, Tzalamouras V, Van Mieghem NM, Colombo A, Latib A.

Am J Cardiol. 2020 Feb 8. pii: S0002-9149(20)30109-0. doi: 10.1016/j.amjcard.2020.02.003. [Epub ahead of print]

PMID:
32098656
9.

GARY-The Largest Registry of Aortic Stenosis Treatment Worldwide.

Hamm CW, Beyersdorf F.

Eur Heart J. 2020 Feb 1;41(6):733-735. doi: 10.1093/eurheartj/ehaa048. No abstract available.

PMID:
32031223
10.

Risk of perioperative coronary stent stenosis or occlusion in patients with previous percutaneous coronary intervention undergoing coronary artery bypass grafting surgery.

Grieshaber P, Oswald I, Albert M, Reents W, Zacher M, Roth P, Niemann B, Dörr O, Krüger T, Nef H, Sodah A, Hamm C, Schlensak C, Diegeler A, Sedding D, Franke U, Boening A.

Eur J Cardiothorac Surg. 2020 Feb 3. pii: ezaa003. doi: 10.1093/ejcts/ezaa003. [Epub ahead of print]

PMID:
32011670
11.

Myeloid-related protein 8/14 and high-sensitivity cardiac troponin I to differentiate type 2 myocardial infarction.

Bormann J, Psyrakis DA, von Jeinsen B, Grün D, Elsner LK, Wolter JS, Weferling M, Diouf K, Kriechbaum S, Troidl C, Dörr O, Nef H, Hamm CW, Liebetrau C, Keller T.

Int J Cardiol. 2020 Apr 1;304:144-147. doi: 10.1016/j.ijcard.2020.01.043. Epub 2020 Jan 21.

PMID:
32008845
12.

Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study.

Chichareon P, Modolo R, Kogame N, Takahashi K, Chang CC, Tomaniak M, Botelho R, Eeckhout E, Hofma S, Trendafilova-Lazarova D, Kőszegi Z, Iñiguez A, Wykrzykowska JJ, Piek JJ, Garg S, Hamm C, Steg PG, Jüni P, Vranckx P, Valgimigli M, Windecker S, Onuma Y, Serruys PW.

Atherosclerosis. 2020 Feb;295:45-53. doi: 10.1016/j.atherosclerosis.2020.01.002. Epub 2020 Jan 15.

PMID:
32006758
13.

The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial.

Ono M, Chichareon P, Tomaniak M, Kawashima H, Takahashi K, Kogame N, Modolo R, Hara H, Gao C, Wang R, Walsh S, Suryapranata H, da Silva PC, Cotton J, Koning R, Akin I, Rensing BJWM, Garg S, Wykrzykowska JJ, Piek JJ, Jüni P, Hamm C, Steg PG, Valgimigli M, Windecker S, Storey RF, Onuma Y, Vranckx P, Serruys PW.

Clin Res Cardiol. 2020 Jan 31. doi: 10.1007/s00392-020-01604-1. [Epub ahead of print]

14.

A case report of sinoatrial arrest caused by temporal lobe epilepsy in subclinical glioblastoma.

Reifart J, Tschernatsch M, Hamm CW, Sperzel J, Hain A.

BMC Cardiovasc Disord. 2020 Jan 30;20(1):30. doi: 10.1186/s12872-020-01325-3.

15.

Transcatheter aortic valve implantation in nonagenarians: insights from the German Aortic Valve Registry (GARY).

Blumenstein J, Möllmann H, Bleiziffer S, Bauer T, Ensminger S, Bekeredjian R, Walther T, Frerker C, Beyersdorf F, Hamm C, Beckmann A.

Clin Res Cardiol. 2020 Jan 28. doi: 10.1007/s00392-020-01601-4. [Epub ahead of print]

PMID:
31989251
16.

Identification of the infarct time in patients with acute myocardial infarction.

Procopio A, Amato F, Cosentino C, Rosa S, Covello C, Merola A, Sabatino J, Luca A, Liebetrau C, Hamm CW, Indolfi C.

Conf Proc IEEE Eng Med Biol Soc. 2019 Jul;2019:1891-1894. doi: 10.1109/EMBC.2019.8857048.

PMID:
31946267
17.

Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial.

Tomaniak M, Chichareon P, Klimczak-Tomaniak D, Takahashi K, Kogame N, Modolo R, Wang R, Ono M, Hara H, Gao C, Kawashima H, Rademaker-Havinga T, Garg S, Curzen N, Haude M, Kochman J, Gori T, Montalescot G, Angiolillo DJ, Capodanno D, Storey RF, Hamm C, Vranckx P, Valgimigli M, Windecker S, Onuma Y, Serruys PW, Anderson R.

Clin Res Cardiol. 2020 Jan 10. doi: 10.1007/s00392-019-01586-9. [Epub ahead of print]

PMID:
31925529
18.

Transcatheter aortic valve implantation with the ACURATE neo valve: indications, procedural aspects and clinical outcomes.

Kim WK, Hengstenberg C, Hilker M, Schäfer U, Rudolph TK, Toggweiler S, Rück A, Søndergaard L, Conradi L, Hamm C, Walther T, Möllmann H; Collaborators.

EuroIntervention. 2020 Apr 3;15(18):e1571-e1579. doi: 10.4244/EIJ-D-19-00908.

19.

High-Content Immunophenotyping and Hierarchical Clustering Reveal Sources of Heterogeneity and New Surface Markers of Human Blood Monocyte Subsets.

Hoffmann J, Fišer K, Liebetrau C, Staubach N, Kost D, Voss S, Heiden AZ, Dörr O, Lipps C, Nef HM, Möllmann H, Hamm CW, Keller T, Troidl C.

Thromb Haemost. 2020 Jan;120(1):141-155. doi: 10.1055/s-0039-1700871. Epub 2019 Dec 30.

PMID:
31887780
20.

Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial.

Tomaniak M, Chichareon P, Takahashi K, Kogame N, Modolo R, Chang CC, Spitzer E, Neumann FJ, Plante S, Hernández Antolin R, Jambrik Z, Gelev V, Brunel P, Konteva M, Beygui F, Morelle JF, Filipiak KJ, van Geuns RJ, Soliman O, Tijssen J, Rademaker-Havinga T, Storey RF, Hamm C, Steg PG, Windecker S, Onuma Y, Valgimigli M, Serruys PW.

Eur Heart J Cardiovasc Pharmacother. 2019 Dec 9. pii: pvz052. doi: 10.1093/ehjcvp/pvz052. [Epub ahead of print]

PMID:
31876907
21.

Inhibition of Protein Prenylation of GTPases Alters Endothelial Barrier Function.

Aslam M, Troidl C, Tanislav C, Rohrbach S, Gündüz D, Hamm CW.

Int J Mol Sci. 2019 Dec 18;21(1). pii: E2. doi: 10.3390/ijms21010002.

22.

Impact of established cardiovascular disease on outcomes in the randomized global leaders trial.

Garg S, Chichareon P, Kogame N, Takahashi K, Modolo R, Chang CC, Tomaniak M, Fath-Ordoubadi F, Anderson R, Oldroyd KG, Stables RH, Kukreja N, Chowdhary S, Galasko G, Hoole S, Zaman A, Hamm CW, Steg PG, Jüni P, Valgimigli M, Windecker S, Onuma Y, Serruys PW.

Catheter Cardiovasc Interv. 2019 Dec 19. doi: 10.1002/ccd.28649. [Epub ahead of print]

PMID:
31854112
23.

The predictive value of intracellular imatinib levels in newly diagnosed chronic myeloid leukemia.

Hillis CM, Jackson Chornenki NL, Bence-Bruckler I, Busque L, Cote Y, Hamm C, Hasegawa W, Kamel-Reid S, Savoie L, Turner AR, Xenocostas A, Lipton JH, Leber B.

Leuk Res. 2020 Jan;88:106285. doi: 10.1016/j.leukres.2019.106285. Epub 2019 Dec 5. No abstract available.

PMID:
31846781
24.

Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial.

Tomaniak M, Chichareon P, Modolo R, Takahashi K, Chang CC, Kogame N, Spitzer E, Buszman PE, van Geuns RM, Valkov V, Steinwender C, Geisler T, Prokopczuk J, Sabaté M, Zmudka K, Rademaker-Havinga T, Tijssen JGP, Jüni P, Hamm C, Steg PG, Onuma Y, Vranckx P, Valgimigli M, Windecker S, Baber U, Anderson R, Dominici M, Serruys PW.

EuroIntervention. 2020 Apr 3;15(18):e1605-e1614. doi: 10.4244/EIJ-D-19-00699.

25.

Association between post-percutaneous coronary intervention bivalirudin infusion and net adverse clinical events: a post hoc analysis of the GLOBAL LEADERS study.

Chang CC, Chichareon P, Modolo R, Takahashi K, Kogame N, Tomaniak M, Gao C, Royaards KJ, Cequier A, Oldroyd K, Steg PG, Hamm C, Jüni P, Valgimigli M, Windecker S, Onuma Y, Stables RH, Jan van Geuns R, Serruys PW.

Eur Heart J Cardiovasc Pharmacother. 2020 Jan 1;6(1):22-30. doi: 10.1093/ehjcvp/pvz051.

PMID:
31841136
26.

Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial.

Takahashi K, Kogame N, Tomaniak M, Chichareon P, Chang CC, Modolo R, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, van Geuns RJ, Dominici M, Huber K, Buszman P, Bolognese L, Tumscitz C, Żmudka K, Aminian A, Vrolix M, Petrov I, Wykrzykowska JJ, de Winter RJ, Hamm C, Steg PG, Onuma Y, Valgimigli M, Windecker S, Vranckx P, Garg S, Serruys PW.

Clin Res Cardiol. 2019 Dec 11. doi: 10.1007/s00392-019-01585-w. [Epub ahead of print]

PMID:
31828504
27.

[Prehospital management of acute coronary syndrome in patients on long-term direct oral anticoagulant treatment].

Schneck E, Schneck FK, Wolter JS, Hamm CW, Mann V, Hauch H, Kemkes-Matthes B, Gräsner JT, Groesdonk HV, Dirkmann D, Sander M, Koch C, Brenck F.

Anaesthesist. 2020 Feb;69(2):108-116. doi: 10.1007/s00101-019-00710-8. Epub 2019 Dec 4. German.

PMID:
31802173
28.

[Artificial intelligence and radiomics in MRI-based prostate diagnostics].

Hamm CA, Beetz NL, Savic LJ, Penzkofer T.

Radiologe. 2020 Jan;60(1):48-55. doi: 10.1007/s00117-019-00613-0. Review. German.

PMID:
31802148
29.

Role of PI3K/Akt and MEK/ERK Signalling in cAMP/Epac-Mediated Endothelial Barrier Stabilisation.

Gündüz D, Troidl C, Tanislav C, Rohrbach S, Hamm C, Aslam M.

Front Physiol. 2019 Nov 7;10:1387. doi: 10.3389/fphys.2019.01387. eCollection 2019.

30.

Outcome of patients with heart failure after transcatheter aortic valve implantation.

Fischer-Rasokat U, Renker M, Liebetrau C, Weferling M, Rolf A, Doss M, Möllmann H, Walther T, Hamm CW, Kim WK.

PLoS One. 2019 Nov 26;14(11):e0225473. doi: 10.1371/journal.pone.0225473. eCollection 2019.

31.

Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial.

Tavenier AH, Hermanides RS, Fabris E, Lapostolle F, Silvain J, Ten Berg JM, Lassen JF, Bolognese L, Cantor WJ, Cequier Á, Chettibi M, Goodman SG, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Ecollan P, Collet JP, Willems FF, Diallo A, Vicaut E, Hamm CW, Montalescot G, van 't Hof AWJ; ATLANTIC investigators.

Thromb Haemost. 2020 Jan;120(1):65-74. doi: 10.1055/s-0039-1700546. Epub 2019 Nov 21.

PMID:
31752042
32.

Eyes of the Heart Team - the interventional imaging specialist: a pathway for future generations.

Piazza N, Delgado V, Mylotte D, Hamm C.

EuroIntervention. 2019 Nov 20;15(10):828-830. doi: 10.4244/EIJV15I10A156. No abstract available.

33.

Drug-coated Balloons for the Treatment of Coronary In-stent Restenosis: A Multicentre, Randomised Controlled Clinical Study.

Hamm CW, Dörr O, Woehrle J, Krackhardt F, Ince H, Zeus T, Bergland J, Piot C, Roubille F, Schult I, Allocco DJ, Nef H.

EuroIntervention. 2019 Nov 19. pii: EIJ-D-19-00051. doi: 10.4244/EIJ-D-19-00051. [Epub ahead of print]

34.

TAVR for mixed aortic valve disease - A good companionship?

Kim WK, Hamm CW.

Int J Cardiol. 2020 Feb 1;300:113-114. doi: 10.1016/j.ijcard.2019.09.031. Epub 2019 Oct 25. No abstract available.

PMID:
31699455
35.

Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the GLOBAL LEADERS Randomized Clinical Trial.

Chichareon P, Modolo R, Kerkmeijer L, Tomaniak M, Kogame N, Takahashi K, Chang CC, Komiyama H, Moccetti T, Talwar S, Colombo A, Maillard L, Barlis P, Wykrzykowska J, Piek JJ, Garg S, Hamm C, Steg PG, Jüni P, Valgimigli M, Windecker S, Onuma Y, Mehran R, Serruys PW.

JAMA Cardiol. 2019 Nov 6:1-10. doi: 10.1001/jamacardio.2019.4296. [Epub ahead of print]

PMID:
31693078
36.

Implementing an adapted Buurtzorg model in an inner city NHS trust.

Hamm C, Glyn-Jones J.

Br J Community Nurs. 2019 Nov 2;24(11):534-537. doi: 10.12968/bjcn.2019.24.11.534.

PMID:
31674231
37.

Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting.

Franzone A, McFadden E, Leonardi S, Piccolo R, Vranckx P, Serruys PW, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, Diletti R, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Hamm C, Steg PG, Heg D, Jüni P, Windecker S, Valgimigli M; GLASSY Investigators.

J Am Coll Cardiol. 2019 Nov 5;74(18):2223-2234. doi: 10.1016/j.jacc.2019.08.1038.

PMID:
31672177
38.

Non-Invasive Approach for Evaluation of Pulmonary Hypertension Using Extracellular Vesicle-Associated Small Non-Coding RNA.

Lipps C, Northe P, Figueiredo R, Rohde M, Brahmer A, Krämer-Albers EM, Liebetrau C, Wiedenroth CB, Mayer E, Kriechbaum SD, Dörr O, Nef H, Hamm CW, Keller T, Troidl C.

Biomolecules. 2019 Oct 29;9(11). pii: E666. doi: 10.3390/biom9110666.

39.

Left atrial roof ablation in patients with persistent atrial fibrillation using the second-generation cryoballoon: benefit or wasted time?

Kuniss M, Akkaya E, Berkowitsch A, Zaltsberg S, Greiss H, Rechner M, Weipert K, Hain A, Hamm CW, Neumann T.

Clin Res Cardiol. 2019 Dec 6. doi: 10.1007/s00392-019-01560-5. [Epub ahead of print]

PMID:
31667623
40.

Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial).

Chang CC, Spitzer E, Chichareon P, Takahashi K, Modolo R, Kogame N, Tomaniak M, Komiyama H, Yap SC, Hoole SP, Gori T, Zaman A, Frey B, Ferreira RC, Bertrand OF, Koh TH, Sousa A, Moschovitis A, van Geuns RJ, Steg PG, Hamm C, Jüni P, Vranckx P, Valgimigli M, Windecker S, Serruys PW, Soliman O, Onuma Y.

Am J Cardiol. 2019 Dec 15;124(12):1833-1840. doi: 10.1016/j.amjcard.2019.08.049. Epub 2019 Sep 26.

PMID:
31648781
41.

Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI.

Takahashi K, Serruys PW, Chichareon P, Chang CC, Tomaniak M, Modolo R, Kogame N, Magro M, Chowdhary S, Eitel I, Zweiker R, Ong P, Ottesen MM, Tijssen JGP, Wykrzykowska JJ, de Winter RJ, Garg S, Stoll HP, Hamm C, Steg PG, Onuma Y, Valgimigli M, Vranckx P, Carrie D, Windecker S.

J Am Coll Cardiol. 2019 Oct 22;74(16):2015-2027. doi: 10.1016/j.jacc.2019.08.997.

PMID:
31623758
42.

Obesity hypoventilation syndrome treated with non-invasive ventilation: Is a switch to CPAP therapy feasible?

Arellano-Maric MP, Hamm C, Duiverman ML, Schwarz S, Callegari J, Storre JH, Schmoor C, Spielmanns M, Galetke W, Windisch W.

Respirology. 2020 Apr;25(4):435-442. doi: 10.1111/resp.13704. Epub 2019 Oct 9.

43.

Challenges of recognizing bicuspid aortic valve in elderly patients undergoing TAVR.

Kim WK, Liebetrau C, Fischer-Rasokat U, Renker M, Rolf A, Doss M, Möllmann H, Nef H, Walther T, Hamm CW.

Int J Cardiovasc Imaging. 2020 Feb;36(2):251-256. doi: 10.1007/s10554-019-01704-8. Epub 2019 Oct 5.

PMID:
31587128
44.

Molecular Imaging of Extracellular Tumor pH to Reveal Effects of Locoregional Therapy on Liver Cancer Microenvironment.

Savic LJ, Schobert IT, Peters D, Walsh JJ, Laage-Gaupp FM, Hamm CA, Tritz N, Doemel LA, Lin M, Sinusas A, Schlachter T, Duncan JS, Hyder F, Coman D, Chapiro J.

Clin Cancer Res. 2020 Jan 15;26(2):428-438. doi: 10.1158/1078-0432.CCR-19-1702. Epub 2019 Oct 3.

PMID:
31582517
45.

Lower mortality in an all-comers aortic stenosis population treated with TAVI in comparison to SAVR.

Möllmann H, Husser O, Blumenstein J, Liebetrau C, Dörr O, Kim WK, Nef H, Tesche C, Hamm CW, Elsässer A, Achenbach S, Gaede L.

Clin Res Cardiol. 2019 Oct 1. doi: 10.1007/s00392-019-01548-1. [Epub ahead of print]

PMID:
31573055
46.

Total gray matter volume is reduced in individuals with bipolar disorder currently treated with atypical antipsychotics.

Birner A, Bengesser SA, Seiler S, Dalkner N, Queissner R, Platzer M, Fellendorf FT, Hamm C, Maget A, Pilz R, Lenger M, Reininghaus B, Pirpamer L, Ropele S, Hinteregger N, Magyar M, Deutschmann H, Enzinger C, Kapfhammer HP, Reininghaus EZ.

J Affect Disord. 2020 Jan 1;260:722-727. doi: 10.1016/j.jad.2019.09.068. Epub 2019 Sep 19.

PMID:
31563071
47.

Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial.

Tomaniak M, Chichareon P, Onuma Y, Deliargyris EN, Takahashi K, Kogame N, Modolo R, Chang CC, Rademaker-Havinga T, Storey RF, Dangas GD, Bhatt DL, Angiolillo DJ, Hamm C, Valgimigli M, Windecker S, Steg PG, Vranckx P, Serruys PW; GLOBAL LEADERS Trial Investigators.

JAMA Cardiol. 2019 Sep 26. doi: 10.1001/jamacardio.2019.3355. [Epub ahead of print]

PMID:
31557763
48.

Ticagrelor with or without Aspirin in High-Risk Patients after PCI.

Mehran R, Baber U, Sharma SK, Cohen DJ, Angiolillo DJ, Briguori C, Cha JY, Collier T, Dangas G, Dudek D, Džavík V, Escaned J, Gil R, Gurbel P, Hamm CW, Henry T, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff M, Kunadian V, Marx SO, Mehta SR, Moliterno D, Ohman EM, Oldroyd K, Sardella G, Sartori S, Shlofmitz R, Steg PG, Weisz G, Witzenbichler B, Han YL, Pocock S, Gibson CM.

N Engl J Med. 2019 Nov 21;381(21):2032-2042. doi: 10.1056/NEJMoa1908419. Epub 2019 Sep 26.

PMID:
31556978
49.

Impact of Ticagrelor Monotherapy on Two-Year Clinical Outcomes in Patients with Long Stenting: A Post Hoc Analysis of the Global Leaders Trial.

Takahashi K, Chichareon P, Modolo R, Kogame N, Chang CC, Tomaniak M, Moschovitis A, Curzen N, Haude M, Jung W, Holmvang L, Garg S, Tijssen JGP, Wykrzykowska JJ, de Winter RJ, Hamm C, Steg PG, Stoll HP, Onuma Y, Valgimigli M, Vranckx P, Windecker S, Serruys PW.

EuroIntervention. 2019 Sep 10. pii: EIJ-D-19-00498. doi: 10.4244/EIJ-D-19-00498. [Epub ahead of print]

50.

Fractional flow reserve and frequency of PCI in patients with coronary artery disease.

Dörr O, Liebetrau C, Weferling M, Hoffmann F, Forderer N, Keller T, Boeder N, Blachutzik F, Keranov S, Bauer P, Bauer T, Hamm CW, Nef H.

Herz. 2019 Sep 4. doi: 10.1007/s00059-019-04848-4. [Epub ahead of print]

PMID:
31485776

Supplemental Content

Support Center